⌘K

Login Start Free

Home/Insiders/Day Lucy

DL

SEC Insider//CIK 0001914510

Day Lucy

CIK 00019145101 companyMENLO PARK, CA

Transactions

12

Companies

1

Filings

8

CIK

0001914510

Recent Transactions

12 trades

Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-02-20−77,000→ 77,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-02-20+38,000→ 118,363 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-06$1.01/sh−5,512→ 75,363 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-05$1.00/sh−3,295→ 80,875 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2025-02-26−93,000→ 93,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-02-26+46,500→ 79,170 total
Sale
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-01-03$1.34/sh−2,957→ 32,670 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+27,500→ 30,627 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-03-15+27,500→ 30,627 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2024-03-15+55,000→ 55,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-02-15+82,300→ 82,300 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+66,000→ 66,000 total

Companies

1

AN2 Therapeutics, Inc.
Chief Financial Officer
$ANTX

Recent Filings

8

Address

C/O AN2 THERAPEUTICS, INC. 1300 EL CAMINO REAL, SUITE 100

MENLO PARK, CA, 94025

View on SEC.gov